We are live on ! Find out more
IMVT icon

Immunovant
IMVT

193 hedge funds and large institutions have $1.62B invested in Immunovant in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 45 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 45

30% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 27

17% more call options, than puts

Call options by funds: $34.5M | Put options by funds: $29.5M

4% more funds holding

Funds holding: 186 → 193 (+7)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

0.28% less ownership

Funds ownership: 56.06% → 55.79% (-0.28%)

21% less capital invested

Capital invested by funds: $2.04B → $1.62B (-$418M)

Holders
193
Holders Change
+7
Holders Change %
+3.76%
% of All Funds
2.59%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
35
Increased
90
Reduced
45
Closed
27
Calls
$34.5M
Puts
$29.5M
Net Calls
+$5.03M
Net Calls Change
-$50.6M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$86.7M
2
BBA
Baker Bros. Advisors
New York
+$78.4M
3
DTC
Deep Track Capital
Connecticut
+$73.2M
4
WP
Woodline Partners
California
+$17.9M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$16.8M

Top Sellers

Rank Fund Capital Flow
1
AGM
Alpine Global Management
New York
-$35.4M
2
Franklin Resources
Franklin Resources
California
-$24.4M
3
BCM
Boxer Capital Management
California
-$20.4M
4
N
Nuveen
North Carolina
-$14.2M
5
RI
RTW Investments
New York
-$13.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
GIM
51
Granahan Investment Management
Massachusetts
$2.94M +$479K +22,920 +15%
DCM
52
DAFNA Capital Management
California
$2.91M +$1.3M +62,000 +57%
WCM Investment Management
53
WCM Investment Management
California
$2.86M -$75.1K -3,588 -2%
ECM
54
ExodusPoint Capital Management
New York
$2.77M +$2.78M +132,887 +455%
Hudson Bay Capital Management
55
Hudson Bay Capital Management
Connecticut
$2.76M +$1.81M +86,660 +116%
PIM
56
Platinum Investment Management
Australia
$2.68M -$948K -45,334 -22%
Millennium Management
57
Millennium Management
New York
$2.62M +$129K +6,143 +4%
Barclays
58
Barclays
United Kingdom
$2.59M -$3.32M -158,789 -51%
BPC
59
Banque Pictet & Cie
Switzerland
$2.52M +$40.1K +1,917 +1%
UBS AM
60
UBS AM
Illinois
$2.39M -$2.91M -139,161 -50%
Verition Fund Management
61
Verition Fund Management
Connecticut
$2.38M +$1.24M +59,244 +74%
Rafferty Asset Management
62
Rafferty Asset Management
New York
$2.37M +$465K +22,213 +19%
Marshall Wace
63
Marshall Wace
United Kingdom
$2.37M +$2.9M +138,477 New
Swiss National Bank
64
Swiss National Bank
Switzerland
$2.25M +$644K +30,800 +31%
TAM
65
TFG Asset Management
Cayman Islands
$2.24M +$2.74M +131,167 New
EAM
66
EFG Asset Management
Oregon
$2.23M +$1.18M +56,375 +76%
Macquarie Group
67
Macquarie Group
Australia
$2.09M – – –
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$2.09M +$771K +36,848 +43%
TC
69
TwinBeech Capital
New York
$1.74M +$1.87M +89,347 +704%
HS
70
HighVista Strategies
Massachusetts
$1.63M +$2M +95,648 New
ACM
71
Aquatic Capital Management
Illinois
$1.59M +$949K +45,343 +95%
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$1.5M -$3.31M -158,123 -64%
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
$1.43M +$54.9K +2,623 +3%
AllianceBernstein
74
AllianceBernstein
Tennessee
$1.28M – – –
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$1.27M +$542K +25,914 +54%
1 2
3
4 5

IMVT Hedge Fund Activity: Q1 2025 in Review

193 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q1 2025, worth a combined $1.62B — down 21% from $2.04B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new IMVT positions and 27 closed out — a net gain of 8 holders — while 90 added to existing stakes and 45 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $86.7M. The largest seller was Alpine Global Management, cutting an estimated $35.4M.

  • 193 institutional investors held Immunovant (IMVT) as of Q1 2025, up from 186 in Q4 2024.
  • Funds reported $1.62B of Immunovant stock for Q1 2025, down 21% quarter-over-quarter.
  • 35 funds opened new Immunovant positions in Q1 2025 and 27 closed out, a net change of +8 holders.
  • The largest Immunovant buyer in Q1 2025 was Fidelity Investments, an estimated $86.7M added.
  • The largest Immunovant seller in Q1 2025 was Alpine Global Management, an estimated $35.4M sold.

Based on aggregated 13F filings for Q1 2025.